- The Washington Times - Tuesday, September 26, 2017

Researchers at Boston University have identified a biomarker that they hope could help identify Chronic Traumatic Encephalopathy (CTE) in living patients.  

In a new study, researchers found higher levels of a protein called CCL11 in the brains of former players with CTE.

The research studied 23 players posthumously diagnosed with CTE, 50 non-athlete brains with Alzheimer’s disease and 18 non-athlete control subjects. 

Not only did this research show the potential for CTE diagnosis during life, but it also offers a possible mechanism for distinguishing between CTE and other diseases,” said Dr Jonathan Cherry, the author of the study, in a release. 

“By making it possible to distinguish between normal individuals, individuals with Alzheimer’s disease, and CTE therapies can become more targeted and hopefully more effective.”

The study said there needs to be more research done on the link between CCL11 and CTE before determining if it can predict the disease. 

Copyright © 2018 The Washington Times, LLC. Click here for reprint permission.

The Washington Times Comment Policy

The Washington Times is switching its third-party commenting system from Disqus to Spot.IM. You will need to either create an account with Spot.im or if you wish to use your Disqus account look under the Conversation for the link "Have a Disqus Account?". Please read our Comment Policy before commenting.

 

Click to Read More

Click to Hide